ICGC ARGO precision medicine: genomic profiling-informed prediction of immunotherapy response in two patients with metastatic head and neck squamous cell carcinoma

Affiliations

• ¹ Section of Ears, Nose and Throat, Department of Surgical Sciences, Dentistry, Gynaecology and Paediatrics, University of Verona, Verona, Italy.
• ² UOC of Oncology, Verona University and Hospital Trust (Azienda Ospedaliera Universitaria Integrata-AOUI-Verona), Verona, Italy.
• ³ Division of Medical Oncology A, Regina Elena National Cancer Institute IRCCS, Rome, Italy.
• ⁴ Section of Pathology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy; ARC-Net Research Centre, University of Verona, Verona, Italy.
• ⁵ Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
• ⁶ Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK. Electronic address: Raffaella.casolino@glasgow.ac.uk.
• ⁷ Section of Pathology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy; ARC-Net Research Centre, University of Verona, Verona, Italy. Electronic address: aldo.scarpa@univr.it.
• ⁸ Section of Innovative Biomedicine-Oncology Area, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy; UOC of Oncology, Verona University and Hospital Trust (Azienda Ospedaliera Universitaria Integrata-AOUI-Verona), Verona, Italy.
• ⁹ ARC-Net Research Centre, University of Verona, Verona, Italy; Section of Innovative Biomedicine-Oncology Area, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy.